Advances in nucleic acid-targeted therapies for cardiovascular disease prevention

医学 核酸 疾病 重症监护医学 生物信息学 计算生物学 内科学 生物 遗传学
作者
Umidakhon Makhmudova,Elisabeth Steinhagen‐Thiessen,Massimo Volpe,Ulf Landmesser
出处
期刊:Cardiovascular Research [Oxford University Press]
卷期号:120 (10): 1107-1125 被引量:2
标识
DOI:10.1093/cvr/cvae136
摘要

Abstract Nucleic acid-based therapies are being rapidly developed for prevention and management of cardiovascular diseases (CVD). Remarkable advancements have been achieved in the delivery, safety, and effectiveness of these therapeutics in the past decade. These therapies can also modulate therapeutic targets that cannot be sufficiently addressed using traditional drugs or antibodies. Among the nucleic acid-targeted therapeutics under development for CVD prevention are RNA-targeted approaches, including antisense oligonucleotides (ASO), small interfering RNAs (siRNA), and novel genome editing techniques. Genetic studies have identified potential therapeutic targets that are suggested to play a causative role in development and progression of CVD. RNA- and DNA-targeted therapeutics can be particularly well delivered to the liver, where atherogenic lipoproteins and angiotensinogen (AGT) are produced. Current targets in lipid metabolism include proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein A (ApoA), apolipoprotein C3 (ApoC3), angiopoietin-like 3 (ANGPTL3). Several large-scale clinical development programs for nucleic acid-targeted therapies in cardiovascular prevention are under way, which may also be attractive from a therapy adherence point of view, given the long action of these therapeutics. In addition to genome editing, the concept of gene transfer is presently under assessment in preclinical and clinical investigations as a potential approach for addressing low-density lipoprotein receptor deficiency. Furthermore, ongoing research is exploring the use of RNA-targeted therapies to treat arterial hypertension by reducing hepatic angiotensinogen (AGT) production. This review summarizes the rapid translation of siRNA and ASO therapeutics as well as gene editing into clinical studies to treat dyslipidemia and arterial hypertension for CVD prevention. It also outlines potential innovative therapeutic options that are likely relevant to the future of cardiovascular medicine.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
SweepingMonk应助玫瑰采纳,获得10
1秒前
1秒前
Oct_Y发布了新的文献求助10
2秒前
2秒前
ceeray23应助地狱跳跳虎采纳,获得10
3秒前
ding应助地狱跳跳虎采纳,获得10
3秒前
nana湘发布了新的文献求助10
3秒前
4秒前
远_09完成签到 ,获得积分10
5秒前
Hanayu发布了新的文献求助10
5秒前
zho发布了新的文献求助10
5秒前
Jessie完成签到,获得积分10
6秒前
7秒前
Jasper应助huangJP采纳,获得10
7秒前
李爱国应助自转无风采纳,获得10
8秒前
风雪丽人发布了新的文献求助200
8秒前
小雷要学习完成签到,获得积分10
8秒前
9秒前
江思瑜发布了新的文献求助10
9秒前
9秒前
乌拉呀哈呀哈完成签到 ,获得积分10
10秒前
11秒前
起风了完成签到,获得积分10
11秒前
JHJ123完成签到,获得积分10
11秒前
12秒前
12秒前
12秒前
xiaopang完成签到,获得积分10
12秒前
yy完成签到,获得积分10
13秒前
Hanayu完成签到,获得积分10
13秒前
专注的西西完成签到 ,获得积分10
13秒前
WW发布了新的文献求助10
14秒前
leo发布了新的文献求助10
15秒前
千阳发布了新的文献求助10
15秒前
15秒前
chendumo完成签到,获得积分10
16秒前
Autumnuer完成签到,获得积分10
16秒前
zhang完成签到 ,获得积分10
17秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
지식생태학: 생태학, 죽은 지식을 깨우다 600
海南省蛇咬伤流行病学特征与预后影响因素分析 500
Neuromuscular and Electrodiagnostic Medicine Board Review 500
ランス多機能化技術による溶鋼脱ガス処理の高効率化の研究 500
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3461806
求助须知:如何正确求助?哪些是违规求助? 3055500
关于积分的说明 9048149
捐赠科研通 2745215
什么是DOI,文献DOI怎么找? 1506088
科研通“疑难数据库(出版商)”最低求助积分说明 695974
邀请新用户注册赠送积分活动 695472